News

NVA237 was licensed to Novartis by Sosei and its co-development partner Vectura Group in a 2005 deal in which the two companies could receive up to $375m in

Valeant Onsolis is an opioid analgesic indicated only for the management of breakthrough pain in cancer patients, 18 years of age and older, who are already receiving and

Osiris Therapeutics has posted a net income of $2.4m for the first quarter of 2010, or $0.07 per diluted share, compared to $14.7m, or $0.45 per diluted share,

IntelliCyt said that the new HTFC Screening System, designed to enable large scale, high throughput, high content screening, takes a new approach to cell-based screening by integrating the

BioGaia said that apart from positive results on gastrointestinal symptoms and hospital stay, supplementation of L reuteri protectis also led to a reduction in number of days of

Generex is expected to continue to monitor and execute the ongoing Generex Oral-lyn study according to protocol and national/international ICH-GCPs. The study’s endpoint is for Generex Oral-lyn to

The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood. The Phase 1 trial,

Under the supply agreement, SkyPeople is expected to supply Boai with 150metric tons of Turnjujube concentrate valued at approximately $2.2m in aggregate for use in the production of

The document is designed as an aid to laboratory and facility management to simplify and facilitate the selection process but also allows evaluation of devices to identify those